Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07832500 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Lot-to-Lot Consistency Clinical Trial of PCV13

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A Phase IIIb clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13)developed by Sinovac Life Science Co., Ltd will be conducted in children aged 2 to 5 years. The objective of the study is to evaluate the the Lot-to-Lot consistency, immunogenicity and safety of Sinovac PCV13. The trial is a randomized, double-blind phase IIIb clinical trial.
Trial Details
NCT Number NCT07832500
Lead Sponsor Sinovac Life Sciences Co., Ltd.
Conditions
(from sponsor)		 Pneumococcal Infectious Diseases
Enrollment 1,125 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov